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Abstract We examined the usefulness of dual-energy com-
puted tomography (DECT) in the evaluation of symptomatic
systemic sclerosis (SSc)-related calcinosis of the hands. We
performed DECT scan of the hands in 16 patients with symp-
tomatic SSc-calcinosis to better characterize the calcinosis,
their locations within the soft tissues, and exclude
monosodium urate (MSU) crystal deposition. We also com-
pared their computed tomography (CT) images to plain radio-
graphs of one hand. Pertinent clinical information from this
cohort was collected. Sixteen SSc patients underwent DECT
and plain X-ray imaging of the hands. Five of the 16 SSc
patients in our cohort had overlap disease, either rheumatoid
arthritis (RA) and/or myopathy. Calcinosis symptoms includ-
ed painful deposits (88 %), soft tissue swelling (66 %), and
recurrent infections (44 %) from these deposits. On DECT,
calcinosis deposits had the same color and density as the bone
and no MSU was found. However, their CT images showed
better details of the calcinosis locations in the soft tissues as
well as the bone destruction, especially if there was overlying
bulky deposits or flexion contractures. These deposits were
most commonly found in the subcutaneous fat pads of the
fingertips, along tendon and muscle groups, or within the car-
pal tunnel. DECT did not confirm MSU in our cohort with
calcinosis. However, CT imaging was superior to plain
radiographs in locating these deposits within the soft tissues
and may be a useful tool to study SSc-calcinosis affecting the
hands, particularly in the setting of progressive hand
deformities.
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Introduction
Calcinosis, the deposition of calcified material in the skin and
subcutaneous soft tissues, is frequently seen in patients with
symptomatic systemic sclerosis (SSc). It has been reported
that approximately 40 % of patients with limited SSc have
calcinosis [1, 2]. Calcium hydroxyapatite [3] is reported to
be the major constituent of SSc-calcinosis. Its pathogenesis
is unknown, and currently, there is no effective cure or pre-
vention. Deposits are commonly found in pressures areas of
the elbows, knees, and hands. The hands may be involved in
up to 70 % of those with SSc-calcinosis [3]. SSc-calcinosis
can be asymptomatic or cause significant morbidity such as
pain, intractable ulcers, and recurrent infections. SSc-
calcinosis may be palpable on exam and/or diagnosed by im-
aging. Plain X-rays [4] are useful to confirm location of cal-
cinosis and could be used to estimate the area of some of these
deposits, whereas ultrasound [2, 3] and computed tomography
(CT) [3, 5] are more helpful in showing the location of these
deposits in the soft tissues and could be useful to quantitate the
burden of calcinosis using volumetric measurements of many
of these bulky and irregularly shaped deposits. Using standard
CT with specialized software to permit dual-energy CT tech-
niques, dual-energy computed tomography (DECT) is an ad-
vanced imaging modality useful for assessing monosodium
urate (MSU) crystal deposition in gout [6–8]. The DECT uti-
lizes two energy beams, usually a combination of 80- and 140-
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kilovoltage peak (kVp) beams, and differences in attenuation
enable differentiation between calcium hydroxyapatite and
MSU crystals. Thus, DECT enables visualization of calcium
deposits by analysis of the chemical content of scanned
materials.
Methods
In this IRB-approved study, we performed DECT imaging
with a 64-slice dual-source CT (Siemens Definition), using
dual-energy application in patients with symptomatic SSc-cal-
cinosis, to better characterize the location and radiographic
details of SSc-calcinosis and exclude MSU. We also com-
pared the DECT to plain X-ray radiographs in all 16 patients.
All had known calcinosis confirmed by prior imaging or phys-
ical exam and met the American College of Rheumatology
(ACR) criteria for definite SSc [9–11], either limited or diffuse
cutaneous SSc. Hand symptoms included painful swelling
surrounding the deposits, redness, or recurrent ulceration from
draining calcinosis. Variables were precisely defined; stan-
dardized abstraction forms were used for data collection.
The variables included gender, age, type of SSc, presence of
overlap with other rheumatic diseases [12, 13] mean years of
SSc, mean years of calcinosis, ischemic digital ulcer history,
nailfold capillaroscopy (using portable DermLite DL100), cal-
c inosis complica t ions , ca lcinosis locat ions, and
autoantibodies.
Results
The clinical, demographic, and serologic characteristics of our
SSc patient cohort are summarized in Table 1. Sixteen SSc
patients with symptomatic calcinosis of the hands confirmed
by physical examination and/or prior imaging underwent
DECT and plain X-ray imaging of the hands. Common calci-
nosis symptoms included pain at the site of deposits (88 %),
soft tissue swelling (63 %) or recurrent infections (44 %) near
the deposits. Their mean age was 59.3 (SD 14.6229, range
29–85) and mean disease duration (from onset of non-
Raynaud symptoms) was 18.5 years (SD 10.0995, range 7–
43 years). Nine of the 16 patients (56 %) had diffuse SSc. Five
SSc patients had overlap disease: three with rheumatoid ar-
thritis (RA), one had both RA and myopathy, and the other
had SSc with myopathy. Most (12/16 or 75 %) developed
calcinosis later in their disease course (mean duration of cal-
cinosis 12.333 years (SD 10.0971, range 1–30)). A long his-
tory of ischemic digital ulcers (69 %) was common.
DECTconfirmed calcinosis had the same density and color
as the bone, and no MSU was found within or near any of
these tumorous deposits. Common locations (see Table 1) in-
cluded the subcutaneous fat pad of the fingertips, along tendon
sheaths of the hands and wrists, within the carpal tunnel, and
adjacent to muscle groups. These deposits ranged in size and
shapes, some rounded, lobulated (popcorn-like), or in clusters
and sheets following tendon andmuscle groups (see Figs. 1, 2,
and 3). Acro-osteolysis was quite common (94 %), and more
than half of this cohort (9/16 patients) had clumps of calcino-
sis adjacent to their sites of bone destruction.
Plain X-ray imaging of the hands was sufficient to confirm
and assess the size and distribution of calcinosis in most of our
cohort, although in five subjects the DECT showed better
Table 1 Clinical and DECT characteristics in SSc-calcinosis cohort
Clinical characteristics Number of patients (%)
(n=16)
Race
Caucasian 13 (81 %)
African-American 3 (19 %)
SSc type
Diffuse 9 (56 %)
Limited 7 (44 %)
SSc patients with overlap disease 5 (31 %)
SSc with RA 3
SSc with RA and myopathy 1
SSc with myopathy 1
Mean age 59.3 (SD±14.6229)
Mean years of SSc from non-Raynaud 18.5 (SD±10.0995)
Mean years of calcinosis 12.33 (SD±10.0971)
Ischemic digital ulcer history 11 (69 %)
Digital pulp loss 12 (75 %)
Abnormal nailfold capillaroscopy 8 (50 %)
Calcinosis complications
Pain 14 (88 %)
Draining ulcer(s) 11 (69 %)
Episodic swelling near deposits 10 (63 %)
Infection 7 (44 %)
Serology
Antinuclear antibodies (ANA) 14 (87 %)
Anti-topoisomerase (Scl 70) 7 (44 %)
Anti-centromere (ACA) 4 (25 %)
Nucleolar antibody 4 (25 %)
Anti-ribonucleoprotein (RNP) 3 (19 %)
RNA polymerase 3 2 (13 %)
Details seen on DECT scan
Calcinosis locations
Fingertip padding 15 (94 %)
Hands 13 (81 %)
Wrists 8 (50 %) (5 in carpal tunnel)
Forearms 5 (31 %)
Presence of acro-osteolysis 15 (94 %)
Calcinosis near acro-osteolysis site 9 (56 %)
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details due to significant flexion deformities or osteopenia in
the presence of large and extensive calcinosis nearby.
Figures 1, 2, and 3 compare representative DECT images with
their plain radiographs of three subjects with significant hand
deformities. Figures 1 and 2 were taken from two subjects
with diffuse cutaneous scleroderma, both presented with in-
creasingly painful flexion contractures of the hands. Their
extensive calcinosis was confirmed incidentally by imaging.
Figure 3 was a subject with limited cutaneous scleroderma and
erosive arthritis, whose extensive joint destruction and bulky
calcinosis were better demonstrated on DECT.
Discussion
We chose DECT to study SSc-calcinosis because of its capac-
ity to show color produced byMSU deposition. If present, we
expected MSU could be detected in the soft tissues, along
Fig. 1 There is extensive soft
tissue calcinosis in the visualized
portion of the distal forearm as
well as within the dorsum of the
right hand. There is also acro-
osteolysis of the fingers with cal-
cinosis in the soft tissues of the
fingertips. On the CAT scan, dor-
sal calcinosis in the forearm ap-
pears to be intramuscular; there
are also extensive calcifications in
the subcutaneous fat along the
volar aspect of the forearm and
within the dorsum of the right
hand
Fig. 2 AP view of right hand
reveals flexion deformities, acro-
osteolysis, and calcinosis of all
five fingers. A representative
sagittal CT image with bone
windows and 3-D volume ren-
dered CTof the third finger shows
a clearer example of the findings
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tendons or ligaments [7, 8], or perhaps as a component within
the calcinosis. All but three of our subjects were older and had
risk factors for gout, although never symptomatic. However,
no MSU deposition was seen and the calcinosis appeared as
white and dense as the bone on DECT.
Calcinosis has been reported to bemore common in limited
cutaneous SSc [1, 2], although most of our cohort with symp-
tomatic SSc-calcinosis had diffuse SSc. Patients with more
than 10 years of SSc-calcinosis typically had limited cutane-
ous SSc. These deposits were typically found along extensor
surfaces of the hands, elbows, and knees, although rare loca-
tions such as the spine and anterior neck [3, 14] have been
reported. Depending on location and size, calcinosis can affect
quality of life and may be inflammatory in up to 20 % of
patients [3, 15].
Calcinosis in SSc-overlap with myopathy can be tu-
morous and found in similar locations in the soft tissues
[3]. Both SSc patients with myopathy from our cohort
had advanced SSc of more than 10 years duration. One
patient had no knowledge of her calcinosis until X-rays
were done to assess her worsening hand deformities
(see Fig. 2). We found both SSc-myopathy patients
had similar appearing calcinosis (limited to their hands)
as the others without overlap disease.
Acro-osteolysis of the fingertips was common. Johnstone
and others [15] reported more severe calcinosis and acro-
osteolysis in patients with tissue damage due to severe digital
ischemia and suggested that this may be a marker of more
severe disease. Similarly, nailfold capillaroscopy has been
helpful in predicting more severe scleroderma complications
including digital ulcers from vasculopathy [16]. We found
abnormal nailfold capillaroscopy in only half of our cohort.
Crystal composition of calcinosis in SSc patients has pre-
viously been identified as calcium hydroxyapatite [3], and the
pathophysiology of how or why these are formed in SSc is
unknown. Increased production of tumor necrosis factor α,
interleukin (IL)-1, IL-6, and other pro-inflammatory cytokines
has been reported in patients with SSc and systemic lupus
erythematosus who have calcinosis [17, 18].
Calcinosis in our patients had a predilection for SQ fat,
attached or near tendon sheaths and along muscle plains.
Most (88 %) patients reported pain (to palpation or with ac-
tivity) at the site of their deposits, even if the area was not
draining, which often affected their activities of daily living.
Ten patients reported soft tissue swelling near the calcinosis
site(s) just prior to spontaneous draining. We found that plain
X-ray imaging of the hands was sufficient to view the size and
distribution of calcinosis in most of our cohort, although in
five subjects CT imaging showed better details due to exten-
sive flexion deformities or osteopenia with nearby large cal-
cinosis deposits. CT imaging foundmore destructive bone and
joint disease in our four SSc patients with rheumatoid arthritis
and calcinosis. Their calcinosis was otherwise similar in dis-
tribution, size, and extent as the rest of our cohort. Interesting,
although their arthritis appeared well controlled clinically, all
4 SSc patients reported progressive and disabling hand defor-
mities over the years. We found CT showed better 3-D details
of calcinosis locations within the soft tissue structures and
demonstrated more clearly how these could contribute to joint
contractures or muscle atrophy. Thus, standard CT imaging
Fig. 3 Oblique volume rendered
3-D CT, a single image from the
coronal CT with bone windows,
and an oblique radiograph of the
left hand are shown: CT imaging
shows better views of the exten-
sive calcinosis surrounding the
carpal bones, distal ulna,
metacarpophalangeal (MCP)
joints, and interphalangeal joints
and extensive periarticular ero-
sions with destructive changes of
the articular cortical surfaces. CT
sections show some calcinosis
deposits deep to the tendons,
others are attached to tendons.
There are flexion deformities of
all fingers and diffuse subluxa-
tions involving the MCP joints
and first carpometacarpal joint
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should be considered in the evaluation of any SSc patient with
progressive hand deformities, especially in the presence of
bulky calcinosis, while DECT could be applied if MSU was
suspected. Newer software is currently being developed to
better differentiate between calcinosis and bone on standard
CT, which would be very useful to quantify bulky calcinosis
using volumetric measurements.
To our knowledge, we are the first group to use DECT to
analyze calcinosis in a cohort of scleroderma patients. Our
limitations include the small population of patients, five of
whom also had overlap disease. However, their calcinosis
did not appear any different or any more extensive than in
those without overlap disease, and further studies are needed
to determine the differences in pathophysiology between
those with and without overlap disease.
Conclusion
Although no MSU crystals were confirmed by DECT in our
cohort, CT imaging is a more useful tool to study patients with
bulky SSc-calcinosis affecting the hands.
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